Close Menu

NEW YORK – Several investment banks announced they have initiated coverage of Berkeley Lights, the cell screening instrument maker that recently went public. 

JP Morgan, Cowen, and William Blair analysts all are bullish on the stock. JP Morgan analyst Tycho Peterson gave it an "Overweight" rating with a price target of $75; Cowen analyst Doug Schenkel and William Blair analyst Brian Weinstein rated it "Outperform," but did not provide a price target.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.